Phase 4 N=26 The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in Humans
Type 2 Diabetes Mellitus
Primary: Endogenous Glucose Production (EGP) — 1.26; 1.25; 0.90; 1.48 mg/kg/min
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=60 Liraglutide and Peripheral Artery Disease
Type 2 Diabetes · Peripheral Arterial Disease
Primary: Peripheral Transcutaneous Oxygen Pressure — 54.2; 43.4 mmHg — p=<0.001
Phase 4 N=66 The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns
Prematurity
Primary: Free Bilirubin (UB) Serum Levels — 10.5; 9.4 Nanomoles/Liter (nM)
Phase 4 N=165 Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
Plasma Cell Neoplasm
Primary: Seroprotection Based on Hemagglutination Antibody Inhibition (HAI) — 32; 22 Participants
Phase 4 N=67 High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
Schizophrenia
Primary: Change in Positive Symptoms of Schizophrenia — 22.6; 24.2 units on a scale
Phase 4 N=155 CBT-I or Zolpidem/Trazodone for Insomnia
Chronic Insomnia
Primary: Change in Insomnia Symptom Severity — -8.05; -7.82; -10.19 change score on a scale
Phase 4 N=122 Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.
Neovascular Age-related Macular Degeneration
Primary: Number of Patients Classified as q12w Fluid-free or Not q12w Fluid-free — 93; 27 Participants
Phase 4 N=58 A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation
Pediculosis Capitis · Lice Infestations · Head Lice
Primary: Proportion of Participants Who Are Completely Free of Live Lice — 0.00; 0.00; .535; .200 proportion of subjects free of live lice — p=.025
Phase 4 N=1,554 The Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Trial
Septic Shock
Primary: 90-day Mortality — 323; 329 Participants
Phase 4 N=77,664 Community Health Azithromycin Trial in Burkina Faso
Childhood Mortality
Primary: All-cause Mortality Rate in Children Aged 1-59 Months — 8.2; 10.0 deaths per 1000 person years
Phase 4 N=21 Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency
Diabetes Mellitus, Type 1
Primary: Capillary Blood Beta-hydroxybutyrate (BOHB) During Outpatient Care — 0.1; 0.2 mmol/L — p=< 0.0001
Phase 4 N=61 Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion
Adolescent Idiopathic Scoliosis
Primary: Total Post Operative Oral Morphine Milligram Equivalents (MME)/Kilogram (Kg) for Hospital Stay — 0.83; 0.92 MME/Kg
Phase 4 N=34 Effect of Coconut Water on Hydration Status in Pediatric Population
Sports Nutrition
Primary: To Determine the Effect of AC vs EO on Hydration Status in Adolescents Who Perform Physical Exercise of Aerobic Competition. — 53; 36; 15; 32 Number participants…
Phase 4 N=50 Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis
Idiopathic Scoliosis · Post-operative Pain
Primary: Patient Satisfaction — 2.75; 2.92; 3.31; 3.13 score on a scale
Phase 4 N=334 A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Actinic Keratosis
Primary: Treatment Satisfaction Questionnaire for Medication Version 9 (TSQM-9) Total Score of Each Components at Day 57 — 73.64; 82.81; 76.94 score on a scale